[
covishield
]Latest from covishield
HC restrains 2 influencers from posting defamatory content against SII, Covishield
The Bombay High Court has restrained two social media influencers from posting defamatory content about Serum Institute of India, its CEO and their Covishield product in an interim application filed by SII in a defamation suit against the influencers. The court directed Yohan Tengra and Ambar Kori to remove the content from Twitter and YouTube. The SII claims the content posted by the duo about multiple deaths being due to the side effects of the vaccine was not only targeted at SII but also its CEO, and sought directions to Twitter and YouTube to take down defamatory content.

Intranasal Covid-19 vaccine sees low response on Day 1
Mumbai's rollout of the intranasal Covid-19 vaccine saw a low response on the first day with only 23 senior citizens taking the booster dose. The vaccine, iNCOVACC by Bharat Biotech, will be administered to those above the age of 60 and eligible six months after their second dose of either Covishield or Covaxin. The state health department recently procured 2 lakh doses, of which BMC procured around 2,000 doses. The vaccine will be given through spot registration at 24 centres across Mumbai.

Poor response to booster dose in Pune as vaccination resumes
PMC health officials since April 1 ran out of vaccine stock and were waiting for the vaccine supply. The civic body this week received 512 doses of the nasal vaccine iNCOVACC

Few takers for booster jabs as Covid-19 cases decline in Bihar
The state reported 179 fresh cases on Wednesday. The daily new cases have been declining since April 22 when the state reported the month’s highest single-day spike of 198 infections

BMC to roll out intranasal Covid vaccine for senior citizens
The vaccination drive will take place in 24 centres – one in every civic ward – across the city. The vaccine will be given through spot registration and addresses of all the locations will be posted daily on BMC’S Twitter account.
